# Stephen Industries

> Stephen Industries is a VC fund in Espoo backing Software, Health Care and Biotechnology. See 18 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Espoo, Finland
- Total investments: 18
- Last investment: Jun 2026
- Lead investor: 22%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/stephen-industries/
- Website: https://www.stephenindustries.com

Stephen Industries is a family owned Finnish company, which place value in technology and innovations that create more environmentally friendly solutions.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $482k–$8.2M |
| Pre-Seed | $330k–$4.3M |
| Series A | $8.3M–$45M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 2 | 11% |
| Health Care | 2 | 11% |
| Biotechnology | 2 | 11% |
| Manufacturing | 2 | 11% |
| Apps | 1 | 6% |

24 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 8 | 44% |
| Series A | 3 | 17% |
| Pre-Seed | 2 | 11% |
| Series B | 2 | 11% |
| Funding Round | 2 | 11% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Finland | 11 | 61% |
| Sweden | 3 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Anferra | Anferra specializes in hydrometallurgy, utilizing methods for resource-efficient recycling of steel industry waste into iron chloride. | $482.3K | Seed | Jun 25, 2026 |  |
| Freepress.ai | Freepress operates with an AI-driven virtual news editor that analyzes hundreds of thousands of publicly available and licensed articles from different countries. | $1.2M | Seed | Dec 08, 2025 |  |
| AlixLabs | AlixLabs offers nanostructure fabrication methods using the atomic layer etching process. This method of nanostructure fabrication uses the atomic layer etching process, which is a damage-free etch process. AlixLabs offers an ALE-based method for producing nanostructures with characteristic sizes less than 20 nm. AlixLabs' technologyfabricates nanostructures beyond the resolution limit of optical and electron beam lithography, with applications in nanoelectronic device fabrication, for example. This invention, among other things, may enable an economically viable method of transistor channel scaling for sub-20 nm technology nodes. | $17.3M | Series A | Nov 20, 2025 |  |
| Cronvall | Cronvall is an online B2B marketplace connecting suppliers to business buyers searching profucts for industrial use. | $4.5M | Seed | Nov 13, 2025 |  |
| HYPERMINE | Hypermine a novel laser-based mineralogy sensing technology to optimize resource recovery and reduce the negative environmental effects of mining. |  | Seed | Jun 18, 2025 |  |
| TILT Biotherapeutics | TILT Biotherapeutics is the leading company globally working in the area of enabling tumor T-cell therapy with oncolytic viruses. TILT is a preclinical stage company working in the field of cancer immunotherapy and will soon translate its unique approach into clinical trials. The company’s patented technology involves utilization of oncolyticviruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR-T) and checkpoint inhibiting antibody therapy. The TILT approach has the potential to achieve similar results in CAR-T therapy of solid tumors as currently achieved for CD19+ hematological tumors. | $25.3M | Series B | May 13, 2025 |  |
| StemSight | StemSight is a cell therapy startup developing novel treatments for blindness operating in Tampere, Finland. | $2.4M | Seed | Feb 13, 2025 |  |
| Gesynta Pharma | Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se | $27.6M | Series B | Jan 20, 2025 |  |
| Hycamite TCD Technologies | Hycamite TCD Technologies is a privately-owned company that commercializes technology developed by several European universities. | $45.3M | Series A | Jan 09, 2025 |  |
| Elmery | Finnish based revenue-stage deep tech company, offering patented, cost-efficient and sustainable refining technologies for critical metals. | $893.5K |  | Sep 29, 2024 |  |

10 of 18 investments shown.

## Co-investors
- [Holdix Oy Ab](https://shizune.co/investors/profile/holdix-oy-ab) — VC Fund, 3 deals together
- [Innovestor](https://shizune.co/investors/profile/innovestor) — VC Fund, 3 deals together
- [Turret Oy](https://shizune.co/investors/profile/turret-oy) — VC Fund, 3 deals together
- [European Innovation Council](https://shizune.co/investors/profile/european-innovation-council) — VC Fund, 2 deals together
- [Industrifonden](https://shizune.co/investors/profile/industrifonden) — VC Fund, 2 deals together
- [Metsa Spring](https://shizune.co/investors/profile/metsa-spring) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Business Finland](https://shizune.co/investors/profile/tekes) — VC Fund
- [Lifeline Ventures](https://shizune.co/investors/profile/lifeline-ventures) — VC Fund
- [Tesi](https://shizune.co/investors/profile/tesi) — VC Fund

## Featured in investor lists
- [All VC Funds in Finland](https://shizune.co/investors/vc-funds-finland)
- [All Investors in Finland](https://shizune.co/investors/investors-finland)
- [Climate VC Funds in Finland](https://shizune.co/investors/climate-vc-funds-finland)
- [Climate Investors in Finland](https://shizune.co/investors/climate-investors-finland)
- [Energy Investors in Finland](https://shizune.co/investors/energy-investors-finland)
- [Energy VC Funds in Finland](https://shizune.co/investors/energy-vc-funds-finland)

## FAQ

### What does Stephen Industries invest in?

Stephen Industries invests primarily in Software, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 18 investments tracked by Shizune back companies in Finland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Stephen Industries's check size?

Stephen Industries typically joins rounds of $482k–$8.2M at Seed, $330k–$4.3M at Pre-Seed and $8.3M–$45M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Stephen Industries participates in.

### When did Stephen Industries last invest?

The most recent investment recorded for Stephen Industries closed in Jun 2026. Shizune tracks 18 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co